GP2 peptide

未知生产厂商

GP2 peptide is under investigation in clinical trial NCT00524277 (Vaccine Therapy in Treating Patients With Breast Cancer).

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

GP2 peptide is under investigation in clinical trial NCT00524277 (Vaccine Therapy in Treating Patients With Breast Cancer).

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

VACCINE FOR THE PREVENTION OF BREAST CANCER RECURRENCE
EP 3238740 A1申请人: HENRY M JACKSON FOUND ADVANCEMENT MILITARY MEDICINE INC优先权: 2008
CN
EP
US
6 件公开
LASSAVIRUS VACCINES
US 2022378903 A1申请人: UNIV LEUVEN KATH优先权: 2019
CN
US
WO
4 件公开
Synthetic peptide-based marker vaccine and diagnostic system for effective control of porcine reproductive and respiratory syndrome (PRRS)
US 10300123 B2申请人: WANG CHANG YI优先权: 2011
US
2 件公开
Arenavirus inhibiting peptides and uses therefor
US 8999925 B2申请人: UNIV TULANE优先权: 2013
US
2 件公开
Polypeptide of affinity GP2 and application thereof
CN 119039393 A申请人: UNIV SUN YAT SEN优先权: 2024
CN